Trump disappointed after healthcare bill defeat

March 25, 2017

Washington, Mar 25: President Donald Trump has expressed disappointment as he faced a severe political defeat after Republicans abandoned their effort to repeal and replace Obamacare policy with a new healthcare bill, due to lack of votes in the US House of Representatives.

trump- copy

Trump's disappointment came after House Speaker Paul Ryan failed to garner enough votes for the passage of the new healthcare bill. Trump had issued an ultimatum to his fellow Republicans after his administration failed to garner enough support for it.

The US House of Representatives –-- similar to the Lok Sabha of the Indian Parliament –-- has 435 members. The Republican party enjoys a simple majority in the House with 235 members.

However due to opposition from some of its own party lawmakers, in particular the one that have grouped themselves under the banner of Freedom Caucus, Ryan, who had been leading the effort on behalf of Trump, could not muster the majority 215 votes.

As a result, in an effort to avoid the humiliation of a defeat, Ryan announced that he was withdrawing the move to have a vote on Affordable Care Act (Obamacare). Unlike India, the US Congress does not have an anti-defection bill, as a result of which US lawmakers are free to exercise their right to vote on a bill as per their wish and not according to dictate of the party leadership.

Blaming the opposition democrats for the failure, Trump warned that now Obamacare is going to stay, people would see a sudden rise in their insurance premium. "It's going to happen (explode). There's not much you can do about it. Bad things are going to happen. There's not much you can do to help it. I've been saying that for a year and a half. It's not sustainable. There's no way out," Trump told reporters at the White House after the bill was withdrawn.

"As we got closer and closer everyone was talking about how wonderful (Obamacare) was. Now it will go back to real life, people will see how bad it is and it's getting much worse. When President Obama left, 2017 was going to be a very bad year for Obamacare," Trump said.

"Going to see explosive premium increases and the deductibles are so high that no one is going to be able to use it," he said.

Having fought and won the presidential elections on the platform of repealing and replacing Obamacare, Trump said he honestly believe that the Democrats will come to the Republicans and say "let's get together and get a great health care bill or plan that's really great" for the people in this country.

"I think that's going to happen," he said. Trump said he was very close to getting enough votes in the House, but fell short of 10-15 votes. "We were very very close. It was a very tight margin. We had no Democratic support," the President said.

"I've been saying for the last year and a half that the best thing we could do, politically speaking, is let Obamacare explode. It's exploding right now," he said. "We couldn't quite get there, we were a small number of votes short. There are many people who don't realise how good our bill was," he said adding that the people don't realise there were two legislative phases to go.

"If (Democrats) got together with us, and got us a real health care bill, I'd be totally okay with that. The losers are Nancy Pelosi and Chuck Schumer, because they own Obamacare. They 100 per cent own it. They have Obamacare for a little while longer until it ceases to exist, which it will at some point in the near future," Trump said.

"When they all become, civilised and get together, and try to work out a great health care bill for the people of this country, we're open to it," he said. Trump told reporters that he would now focus his attention on tax reforms.

"We are going, right now, for tax reform. Which we could've done earlier but this really would've worked out better if we could've had Democrat support. Remember we had no Democrat support. So now we're going to go for tax reform,"he said.

The President replied in negative when he was asked if he felt betrayed by the Freedom caucus within the Republican Party. "I'm not betrayed. They're friends of mine. I'm disappointed because we could've had it. So I'm disappointed. I'm a little surprised I could tell you. We really had it, it was pretty much there. but what's going to come out of it is a better bill," he said.

"Because there were things in his bill that I didn't particularly like. But both parties can get together and do real health care. Obamacare was rammed down everyone's throat. 100 per cent Democrat. Having bipartisan would be a big, big improvement. I'm disappointed but I'm friends of mine. You know this is a very hard time for them," Trump said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 10,2020

Melbourne, Apr 10: Scientists have identified six drug candidates from more than 10,000 compounds that may help treat COVID-19.

The research, published in the journal Nature, tested the efficacy of approved drugs, drug candidates in clinical trials and other compounds.

"Currently there are no targeted therapeutics or effective treatment options for COVID-19," said Professor Luke Guddat from the University of Queensland in Australia.

"In order to rapidly discover lead compounds for clinical use, we initiated a programme of high-throughput drug screening, both in laboratories and also using the latest computer software to predict how different drugs bind to the virus," Guddat said.

The project targeted the main COVID-19 virus enzyme, known as the main protease or Mpro, which plays a pivotal role in mediating viral replication, the researchers said.

This makes it an attractive drug target for this virus, and as people don't naturally have this enzyme, compounds that target it are likely to have low toxicity, they said.

"We add the drugs directly to the enzyme or to cell cultures growing the virus and assess how much of each compound is required to stop the enzyme from working or to kill the virus. If the amount is small, then we have a promising compound for further studies," said Guddat.

After assaying thousands of drugs, researchers found of the six that appear to be effective in inhibiting the enzyme, one is of particular interest.

"We're particularly looking at several leads that have been subjected to clinical trials including for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis and cancer," Guddat said.

Researchers said compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.

"With continued and up-scaled efforts we are optimistic that new candidates can enter the COVID-19 drug discovery pipeline in the near future," Guddat said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 25,2020

Karachi, May 25: The pilot of the Pakistan International Airlines (PIA)'s crashed plane ignored three warnings from the air traffic controllers about the aircraft's altitude and speed before the landing, saying he was satisfied and would handle the situation, according to a report on Monday.

The national flag carrier's PK-8303 tragedy on Friday, in which 97 people were killed and two miraculously survived, is one of the most catastrophic aviation disasters in the country's history.

The Airbus A-320 from Lahore to Karachi was 15 nautical miles from the Jinnah International Airport, flying at an altitude of 10,000 feet above the ground instead of 7,000 when the Air Traffic Control (ATC) issued its first warning to lower the plane's altitude, Geo News quoted an ATC report as saying.

Instead of lowering the altitude, the pilot responded by saying that he was satisfied. When only 10 nautical miles were left till the airport, the plane was at an altitude of 7,000 feet instead of 3,000 feet, it said.

The ATC issued a second warning to the pilot to lower the plane's altitude. However, the pilot responded again by stating that he was satisfied and would handle the situation, saying he was ready for landing, the report said.

The report said that the plane had enough fuel to fly for two hours and 34 minutes, while its total flying time was recorded at one hour and 33 minutes.

Pakistani investigators are trying to find out if the crash is attributable to a pilot error or a technical glitch.

According to a report prepared by the country's Civil Aviation Authority (CAA), the plane's engines had scraped the runway thrice on the pilot's first attempt to land, causing friction and sparks recorded by the experts.

When the aircraft scraped the ground on the first failed attempt at landing, the engine's oil tank and fuel pump may have been damaged and started to leak, preventing the pilot from achieving the required thrust and speed to raise the aircraft to safety, the report said.

The pilot made a decision "on his own" to undertake a "go-around" after he failed to land the first time. It was only during the go-around that the ATC was informed that landing gear was not deploying, it said.

"The pilot was directed by the air traffic controller to take the aircraft to 3,000 feet, but he managed only 1,800. When the cockpit was reminded to go for the 3,000 feet level, the first officer said 'we are trying'," the report said.

Experts said that the failure to achieve the directed height indicates that the engines were not responding. The aircraft, thereafter, tilted and crashed suddenly.

The flight crashed at the Jinnah Garden area near Model Colony in Malir on Friday afternoon, minutes before its landing in Karachi's Jinnah International Airport. Eleven people on the ground were injured.

The probe team, headed by Air Commodore Muhammad Usman Ghani, President of the Aircraft Accident and Investigation Board, is expected to submit a full report in about three months.

According to the PIA's engineering and maintenance department, the last check of the plane was done on March 21 this year and it had flown from Muscat to Lahore a day before the crash.

In the wake of the COVID-19 pandemic, the Pakistan government had allowed the limited domestic flight operations from five major airports - Islamabad, Karachi, Lahore, Peshawar and Quetta - from May 16.

After the plane tragedy, the PIA has called off its domestic operation.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 29,2020

If everything goes as Russia’s expectation, it will be world’s first country to approve a coronavirus vaccine for widespread in the second week of August despite safety and efficacy concerns, according to a report. The adenoviral vector-based vaccine developed by Russian military and government researchers is currently in phase 2 trials.

According to a report from CNN, Russian officials are hoping to get approval for the COVID-19 vaccine developed by the Moscow-based Gamaleya Institute on Agust 10 or even before that. The officials told the outlet that the vaccine will be approved for public use with frontline healthcare workers receiving it first.

“It’s a Sputnik moment,” said Kirill Dmitriev, head of Russia’s sovereign wealth fund, which is financing Russian vaccine research, referring to the successful 1957 launch of the world’s first satellite by the Soviet Union, according to CNN.

“Americans were surprised when they heard Sputnik’s beeping. It’s the same with this vaccine. Russia will have got there first,” he was quoted as saying.

However, Russia is yet to release the scientific data on its coronavirus vaccine trials, hence, questions remain about the safety and efficacy of the vaccine, said the report. The vaccine is in the second phase of testing with developers planning to launch the phase 3 trials sometime after August 3.

Earlier, Interfax reported, citing Health Minister Mikhail Murashko, that the vaccine will be widely used in parallel with phase 3 trials. He said the country plans to vaccinate medics who are at high-risk for COVID-19 next month before clinical trials are completed.

Murashko added that individuals at higher risk of getting infected with the coronavirus such as older people or those with health conditions will also be prioritised for the vaccine, although he did not estimate or reveal when that would happen. The minister added 800 people will be recruited for the phase 3 trials.

Meanwhile, health officials were more cautious considering the fact that human testing of the vaccine is incomplete, and the state registration is expected to begin after August 3, reported The Moscow Times.

On Monday, Moderna and Pfizer announced the commencement of the final phase 3 trials of their candidate vaccines against the SARS-CoV-2 virus, which has so far claimed at least 654,477 lives and infected 16,514,500 people worldwide. 

Researchers will recruit up to 30,000 volunteers in separate trials both backed by the US government. India's first indigenous coronavirus vaccine, COVAXIN, is undergoing phase 1 human clinical trials across the country. More than 150 COVID-19 vaccines are being developed all over the world with at least six candidates already in late-stage clinical trials.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.